Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s stock price dropped 2.7% on Monday . The stock traded as low as $16.65 and last traded at $16.65. Approximately 2,174 shares changed hands during mid-day trading, a decline of 97% from the average daily volume of 82,539 shares. The stock had previously closed at $17.11.
Gyre Therapeutics Stock Down 3.4 %
The stock has a market cap of $1.41 billion, a P/E ratio of -0.79 and a beta of 2.11. The stock’s fifty day moving average price is $17.65.
About Gyre Therapeutics
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Read More
- Five stocks we like better than Gyre Therapeutics
- What is the Nikkei 225 index?
- The 3 Hottest Insiders Buys This Month
- How to Use Stock Screeners to Find Stocks
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- 3 Stocks to Consider Buying in October
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
